Prelude Therapeutics Incorporated
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $132,277,000.
Profit Margin
| 2018 | 0 | -14.68M | |
|---|---|---|---|
| 2019 | 0 | -27.57M | |
| 2020 | 0 | -56.92M | |
| 2021 | 0 | -110.77M | |
| 2022 | 0 | -107.33M | |
| 2023 | 0 | -121.83M |
PRLD Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 1.16M | 3.04M | 2.24M | 542K | 382K | 0 |
Gross profit | -1.16M | -3.04M | -2.24M | -542K | -382K | 0 |
Operating exp. | ||||||
Research and development | 103.39M | 92.88M | 86.77M | 48.17M | 24.27M | 12.62M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 132.27M | 123.54M | 113.73M | 58.76M | 28.10M | 14.97M |
Operating income | -132.27M | -123.54M | -113.73M | -58.76M | -28.10M | -14.97M |
Other income (expenses), net | 10.44M | 8.10M | 2.04M | 1.83M | 539K | 295K |
Income before tax | -121.83M | -115.43M | -111.69M | -56.92M | -27.57M | -14.68M |
Income tax expense | 0 | -8.10M | -915K | 335.70K | 0 | 295K |
Net income | -121.83M | -107.33M | -110.77M | -56.92M | -27.57M | -14.68M |
Earnings per share | ||||||
Basic EPS | -2.02 | -2.27 | -2.33 | -1.3 | -0.85 | -0.46 |
Diluted EPS | -2.02 | -2.27 | -2.33 | -1.3 | -0.85 | -0.46 |
| Data source | Data source | Data source | Data source |